These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 23291438)

  • 1. Sensitive HPLC-PDA determination of tamoxifen and its metabolites N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in human plasma.
    Antunes MV; Rosa DD; Viana Tdos S; Andreolla H; Fontanive TO; Linden R
    J Pharm Biomed Anal; 2013 Mar; 76():13-20. PubMed ID: 23291438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultra-high performance liquid chromatography tandem mass spectrometric method for the determination of tamoxifen, N-desmethyltamoxifen, 4-hydroxytamoxifen and endoxifen in dried blood spots--development, validation and clinical application during breast cancer adjuvant therapy.
    Antunes MV; Raymundo S; de Oliveira V; Staudt DE; Gössling G; Peteffi GP; Biazús JV; Cavalheiro JA; Tre-Hardy M; Capron A; Haufroid V; Wallemacq P; Schwartsmann G; Linden R
    Talanta; 2015 Jan; 132():775-84. PubMed ID: 25476377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a high-performance liquid chromatography method with fluorescence detection for the routine quantification of tamoxifen, endoxifen and 4-hydroxytamoxifen in plasma from breast cancer patients.
    Rangel-Méndez JA; Graniel-Sabido MJ; Sánchez-Cruz JF; Moo-Puc R
    Biomed Chromatogr; 2019 Apr; 33(4):e4462. PubMed ID: 30536934
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimizing high-performance liquid chromatography method with fluorescence detection for quantification of tamoxifen and two metabolites in human plasma: application to a clinical study.
    Zhu YB; Zhang Q; Zou JJ; Yu CX; Xiao DW
    J Pharm Biomed Anal; 2008 Jan; 46(2):349-55. PubMed ID: 18037598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An ultra performance liquid chromatography-tandem MS assay for tamoxifen metabolites profiling in plasma: first evidence of 4'-hydroxylated metabolites in breast cancer patients.
    Dahmane E; Mercier T; Zanolari B; Cruchon S; Guignard N; Buclin T; Leyvraz S; Zaman K; Csajka C; Decosterd LA
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Dec; 878(32):3402-14. PubMed ID: 21094101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in plasma.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    J Chromatogr B Biomed Appl; 1996 Apr; 678(2):317-23. PubMed ID: 8738037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantification of tamoxifen and three metabolites in plasma by high-performance liquid chromatography with fluorescence detection: application to a clinical trial.
    Lee KH; Ward BA; Desta Z; Flockhart DA; Jones DR
    J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Jul; 791(1-2):245-53. PubMed ID: 12798184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An UPLC-MS/MS method for separation and accurate quantification of tamoxifen and its metabolites isomers.
    Arellano C; Allal B; Goubaa A; Roché H; Chatelut E
    J Pharm Biomed Anal; 2014 Nov; 100():254-261. PubMed ID: 25173109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a methodology to quantify tamoxifen and endoxifen in breast cancer patients by micellar liquid chromatography and validation according to the ICH guidelines.
    Aranda EO; Esteve-Romero J; Rambla-Alegre M; Peris-Vicente J; Bose D
    Talanta; 2011 Apr; 84(2):314-8. PubMed ID: 21376950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Volumetric Absorptive Microsampling as a New Biosampling Tool for Monitoring of Tamoxifen, Endoxifen, 4-OH Tamoxifen and N-Desmethyltamoxifen in Breast Cancer Patients.
    Maggadani BP; Harmita ; Haryono SJ; Rinaldi MR; Harahap Y
    Drug Des Devel Ther; 2021; 15():2417-2430. PubMed ID: 34113081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of tamoxifen and its main metabolites in plasma samples from breast cancer patients by micellar liquid chromatography.
    Peris-Vicente J; Ochoa-Aranda E; Bose D; Esteve-Romero J
    Talanta; 2015 Jan; 131():535-40. PubMed ID: 25281137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a quantitative assay for the determination of tamoxifen and its five main phase I metabolites in human serum using liquid chromatography coupled with tandem mass spectrometry.
    Teunissen SF; Jager NG; Rosing H; Schinkel AH; Schellens JH; Beijnen JH
    J Chromatogr B Analyt Technol Biomed Life Sci; 2011 Jun; 879(19):1677-85. PubMed ID: 21543272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast method for simultaneous quantification of tamoxifen and metabolites in dried blood spots using an entry level LC-MS/MS system.
    Tré-Hardy M; Capron A; Antunes MV; Linden R; Wallemacq P
    Clin Biochem; 2016 Nov; 49(16-17):1295-1298. PubMed ID: 27498307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reductive amination-assisted quantitation of tamoxifen and its metabolites by liquid phase chromatography tandem mass spectrometry.
    Liang SS; Wang TN; Chiu CC; Kuo PL; Huang MF; Liu MC; Tsai EM
    J Chromatogr A; 2016 Feb; 1434():64-9. PubMed ID: 26814364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimised separation of E- and Z- isomers of tamoxifen, and its principal metabolites using reversed-phase high performance liquid chromatography.
    Manns JE; Hanks S; Brown JE
    J Pharm Biomed Anal; 1998 Jan; 16(5):847-52. PubMed ID: 9535197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Importance of highly selective LC-MS/MS analysis for the accurate quantification of tamoxifen and its metabolites: focus on endoxifen and 4-hydroxytamoxifen.
    Jager NG; Rosing H; Linn SC; Schellens JH; Beijnen JH
    Breast Cancer Res Treat; 2012 Jun; 133(2):793-8. PubMed ID: 22388692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct determination of tamoxifen and its four major metabolites in plasma using coupled column high-performance liquid chromatography.
    Fried KM; Wainer IW
    J Chromatogr B Biomed Appl; 1994 May; 655(2):261-8. PubMed ID: 8081472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of tamoxifen and three of its phase-I metabolites in human plasma by liquid chromatography/triple-quadrupole mass spectrometry.
    Binkhorst L; Mathijssen RH; Ghobadi Moghaddam-Helmantel IM; de Bruijn P; van Gelder T; Wiemer EA; Loos WJ
    J Pharm Biomed Anal; 2011 Dec; 56(5):1016-23. PubMed ID: 21872414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fast and Adequate Liquid Chromatography-Tandem Mass Spectrometric Determination of Z-endoxifen Serum Levels for Therapeutic Drug Monitoring.
    de Krou S; Rosing H; Nuijen B; Schellens JH; Beijnen JH
    Ther Drug Monit; 2017 Apr; 39(2):132-137. PubMed ID: 28045782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid-phase extraction and high-performance liquid chromatographic determination of tamoxifen and its major metabolites in breast tumour tissues.
    MacCallum J; Cummings J; Dixon JM; Miller WR
    J Chromatogr B Biomed Sci Appl; 1997 Sep; 698(1-2):269-75. PubMed ID: 9367217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.